HIGHLIGHTS
- who: Ping Liu from the United States Zhengzhou, China United States have published the research: Prognostic stratification based on m5C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma, in the Journal: (JOURNAL)
- what: The past research on m5C regulators-mediated methylation modification model in HCC was focused on the effect of a single TME cell type or single m 5 C regulator alone on tumor development, and the overall TME infiltration portrait mediated by several m 5 C regulators remains to be comprehensively recognized. The research provides further verifications that patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.